Local treatment for pulmonary oligometastases (one to five lesions) using metastasectomy
or stereotactic ablative radiotherapy (SABR) was investigated in a cohort that received …

An increasing body of experience suggests that oligometastasis represents a minimal
metastatic state with the potential for cure or prolonged survival in selected patients treated …

Introduction Hypofractionated stereotactic body radiotherapy (SBRT) is an emerging
noninvasive technique for the treatment of oligometastatic cancer. The use of small numbers …

Background and purpose Stereotactic ablative radiotherapy (SABR; or stereotactic body
radiotherapy, SBRT) emerges as treatment option for pulmonary oligometastatic disease …

Introduction Pulmonary oligometastases have conventionally been managed with surgery
and/or systemic therapy. However, given concerns about the high cost of systemic therapy …

Background Oligometastases can be divided into sync-oligometastases and oligo-
recurrence. The difference is whether the primary site is uncontrolled or controlled. The goal …

Background Successful local therapy for oligometastases may lead to longer survival. The
purpose of this multicentre retrospective study was to investigate factors affecting the local …

Background: Oligometastases refers to a state of limited metastatic disease. The use of local
ablative therapies to patients with oligometastases can result in durable state of remission or …

It is not clear as to which is the best treatment among surgery and stereotactic radiotherapy
(SBRT) for lung oligometastases. A systematic review of literature with a priori selection …

Background: Stereotactic body radiotherapy (SBRT) for pulmonary oligometastatic disease
achieves excellent treatment outcomes in terms of local control and toxicity. Patients treated …